tiprankstipranks
Trending News
More News >
Coheris (FR:COH)
:COH

Coheris (COH) AI Stock Analysis

Compare
0 Followers

Top Page

FR:COH

Coheris

(COH)

Select Model
Select Model
Select Model
Outperform 73 (OpenAI - 5.2)
Rating:73Outperform
Price Target:
€16.50
▲(14.58% Upside)
The score is driven primarily by strong financial performance (high margins, low leverage, and solid free-cash-flow conversion). Technicals are supportive but not strongly bullish due to mixed momentum signals. Valuation is reasonable but not compelling given the P/E and low dividend yield.
Positive Factors
High margins
Sustained high gross and net margins indicate a scalable, software-driven cost structure and pricing power. Over months this supports reinvestment in product and sales, funds profitability during growth, and creates a durable buffer against cyclical revenue dips.
Strong cash generation
Robust free cash flow and strong operating-cash-flow-to-net-income conversion enhance financial flexibility. This durable cash generation capacity supports R&D, implementation capacity, selective M&A, or shareholder returns without heavy reliance on external financing.
Low leverage
A conservative capital structure and low leverage reduce refinancing and liquidity risk, allowing the company to fund strategic investments and weather sector shocks. This stability underpins long-term operational planning and preserves optionality.
Negative Factors
Modest scale
A relatively small absolute revenue base limits economies of scale in sales, R&D and marketing. Over the medium term this constrains the firm's ability to match larger competitors' investment pace and increases vulnerability to losing a few sizeable clients.
Reliance on large partnerships
Dependence on large partner-led implementations concentrates revenue and can make sales lumpy. Structurally, this creates bargaining-power asymmetries and execution risk: setbacks or reduced spend by a major partner would materially affect multi-month cash flows and growth.
Industry concentration
A focused exposure to healthcare and life sciences increases sensitivity to sector-specific regulatory changes, reimbursement cycles, and budgetary constraints. Over a multi-month horizon this can constrain addressable market growth and amplify demand variability.

Coheris (COH) vs. iShares MSCI France ETF (EWQ)

Coheris Business Overview & Revenue Model

Company DescriptionCoheris SA provides customer relationship management (CRM), customer insight, and analytics solutions in France and internationally. The company offers CRM Customer Service, a customer relationship management solution; Sales Force CRM, a sales force management solution; and Marketing CRM that optimizes the marketing activities and emailing campaigns. It also provides Coheris CRM Nomad, a solution to manage sales operations offline; and Coheris CRM Merch, a tool that enhance merchandising to support the negotiation and the decision-making. In addition, the company offers cloud solution, a secure technical infrastructure. It serves customers in insurance and mutual insurance; retail; banking and finance; cosmetics and pharmaceuticals; CPG; education, studies, and research; media, studies, and telecommunication; public; services; and other sectors. The company was founded in 1994 and is based in Suresnes, France. Coheris SA is as subsidiary of ChapsVision.
How the Company Makes MoneyCoheris generates revenue through multiple streams, primarily by selling software licenses, offering subscription-based services, and providing consulting and implementation services. The company charges clients for its software products, which can be purchased outright or accessed via a recurring subscription model. Additionally, Coheris provides professional services such as training, support, and consulting, which are billed separately. Key partnerships with healthcare providers, pharmaceutical companies, and research institutions also contribute significantly to its earnings, as these collaborations often lead to large-scale implementations of Coheris's solutions, enhancing customer retention and driving long-term revenue growth.

Coheris Financial Statement Overview

Summary
Strong overall fundamentals supported by solid revenue growth (2020–2024), high gross margin (67.6%), and robust profitability (net margin 23.1%, EBIT 21.6%, EBITDA 40.9%). Balance sheet leverage is low (D/E 0.23) with a stable equity ratio (57.3%), and cash conversion is strong with meaningful free cash flow (€4.99M) and OCF/NI of 1.45.
Income Statement
85
Very Positive
Coheris has demonstrated solid revenue growth over recent years, with revenue increasing from €11.4 million in 2020 to €14.9 million in 2024. The company enjoys a strong gross profit margin of 67.6% in 2024, indicating efficient cost management. Net profit margin improved to 23.1% in 2024, showcasing robust profitability. EBIT and EBITDA margins also remain strong at 21.6% and 40.9% respectively, reflecting operational efficiency and effective cost control.
Balance Sheet
78
Positive
The balance sheet reflects a healthy financial position with a debt-to-equity ratio of 0.23 in 2024, indicating low leverage. Return on Equity (ROE) improved to 16.6%, signifying better returns for shareholders. The equity ratio stands at 57.3%, suggesting a stable capital structure. Overall, Coheris maintains a balanced and strong financial standing with manageable debt levels.
Cash Flow
82
Very Positive
Coheris has shown consistent free cash flow generation, with a notable free cash flow of €4.99 million in 2024. The operating cash flow to net income ratio is robust at 1.45, illustrating strong cash conversion efficiency. The free cash flow to net income ratio is 1.45, indicating that the company effectively converts its net income into free cash flow. The free cash flow growth rate shows a positive trend, enhancing liquidity and financial flexibility.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue15.47M14.94M14.62M13.84M12.40M11.40M
Gross Profit3.98M10.10M2.69M2.18M1.33M-1.17M
EBITDA6.33M6.11M5.30M4.54M3.36M763.00K
Net Income3.71M3.44M3.05M4.43M996.00K-2.02M
Balance Sheet
Total Assets39.18M36.16M38.07M34.96M31.89M23.63M
Cash, Cash Equivalents and Short-Term Investments811.00K359.00K188.00K513.00K1.57M5.29M
Total Debt4.17M4.80M6.16M7.27M7.56M4.29M
Total Liabilities17.04M15.45M20.33M20.20M21.90M14.65M
Stockholders Equity22.14M20.72M17.74M14.76M10.00M8.98M
Cash Flow
Free Cash Flow3.42M4.99M4.44M4.79M4.90M970.00K
Operating Cash Flow5.05M4.99M4.44M6.54M6.59M2.54M
Investing Cash Flow-1.65M-1.69M-1.71M-1.63M-1.72M-1.58M
Financing Cash Flow-3.81M-3.12M-3.06M-6.08M-8.69M1.40M

Coheris Technical Analysis

Technical Analysis Sentiment
Positive
Last Price14.40
Price Trends
50DMA
14.31
Positive
100DMA
13.46
Positive
200DMA
10.85
Positive
Market Momentum
MACD
0.23
Negative
RSI
59.86
Neutral
STOCH
91.85
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For FR:COH, the sentiment is Positive. The current price of 14.4 is below the 20-day moving average (MA) of 14.51, above the 50-day MA of 14.31, and above the 200-day MA of 10.85, indicating a bullish trend. The MACD of 0.23 indicates Negative momentum. The RSI at 59.86 is Neutral, neither overbought nor oversold. The STOCH value of 91.85 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for FR:COH.

Coheris Peers Comparison

Overall Rating
UnderperformOutperform
Sector (55)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
73
Outperform
€86.71M23.3918.06%0.55%6.71%7.79%
55
Neutral
$6.65B3.83-15.92%6.20%10.91%7.18%
45
Neutral
€3.24M-2.44-34.48%-288.35%
* General Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
FR:COH
Coheris
15.25
6.28
69.99%
FR:ALPRG
PROLOGUE
0.26
-0.01
-5.20%
FR:EOS
Acteos SA
0.96
-0.03
-3.23%
FR:MLPAC
Pacte Novation
8.15
-1.65
-16.84%
FR:ALVGO
Vogo SA
2.33
-1.07
-31.47%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jan 24, 2026